Isto Biologics, a US-based biologics company dedicated to advancing bone healing, has acquired NovaBone Products, a developer and manufacturer of synthetic bone graft products, from UK-listed Halma, the global group [...]
US: Halma sells NovaBone to Keensight-backed Isto Biologics for US$60m
